𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

✍ Scribed by Papp, Kim A.; Leonardi, Craig; Menter, Alan; Ortonne, Jean-Paul; Krueger, James G.; Kricorian, Gregory; Aras, Girish; Li, Juan; Russell, Chris B.; Thompson, Elizabeth H.Z.; Baumgartner, Scott

Book ID
120448996
Publisher
Massachusetts Medical Society
Year
2012
Tongue
English
Weight
477 KB
Volume
366
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brodalumab and ixekizumab, anti-interleu
Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal : ORIGINAL ARTICLE: Papp KA, Leonardi C, Menter A et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 2012; 366: 1181–9.ORIGINAL ARTICLE: Leonardi C, Matheson R, Zachariae C, et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 2012; 366: 1190–9.
✍ Ph. I. Spuls; L. Hooft 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB